Rhodobacter azotoformans LPS (RAP99-LPS) Is a TLR4 Agonist That Inhibits Lung Metastasis and Enhances TLR3-Mediated Chemokine Expression
The lipopolysaccharides (LPSs) of Rhodobacter are reported to be TLR4 antagonists. Accordingly, the extract of Rhodobacter azotoformans (RAP99) is used as a health supplement for humans and animals in Japan to regulate immune responses in vivo. We previously analyzed the LPS structure of RAP99 (RAP9...
Main Authors: | Kaoru Murakami, Daisuke Kamimura, Rie Hasebe, Mona Uchida, Nobuya Abe, Reiji Yamamoto, Jing-Jing Jiang, Yasuhiro Hidaka, Yuko Nakanishi, Shuzo Fujita, Yuki Toda, Nobuhiro Toda, Hiroki Tanaka, Shizuo Akira, Yuki Tanaka, Masaaki Murakami |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.675909/full |
Similar Items
-
Identification of key residues that confer Rhodobacter sphaeroides LPS activity at horse TLR4/MD-2.
by: Katherine L Irvine, et al.
Published: (2014-01-01) -
Association between TLR4 and PTEN Involved in LPS-TLR4 Signaling Response
by: Huahua Yin, et al.
Published: (2016-01-01) -
TLR4 Response to LPS Is Reinforced by Urokinase Receptor
by: Yulia Kiyan, et al.
Published: (2020-12-01) -
Recognition of LPS by TLR4: Potential for Anti-Inflammatory Therapies
by: Reindert Nijland, et al.
Published: (2014-07-01) -
Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression
by: Qiong Xue, et al.
Published: (2021-07-01)